Congress spokesman seeks Centre's attention over fake news
New Delhi, July 6 : Congress spokesman Randeep Singh Surjewala on Friday sought the Centre's attention towards the menace of fake news circulating on social media that maligns the image of reputed persons.
"Modi Govt needs to crackdown on this ‘Fake News Factory' that is unleashed on SM (social media) by BJP supporters. Lies and photoshop driven fakery are being spread that violate 153 A, 295 A, 500 and 505(2) of the IPC (Indian Penal Code)," Surjewala tweeted.
Through his tweet, the leader also urged Union Home Minister Rajnath Singh to curb the peril. "Hope @HMOIndia and @DelhiPolice under Rajnath Singh ji will act against culprits."
Surjewala's remarks come after Indiaflare.com published a manufactured quote attributing to the Congress leader.
It said: "Mohammed Irfan (Mandsaur rapist) cannot be considered a rapist because Islam permits the rape of women from other religion. He should be released."
This was the same narrative pushed by the fake news website in its article on 'Muslims demanding the release of Mandsaur rapist', Surjewala said.
He said the fake quote was shared on "Join and Support PM Modi 2019" by one Anurag Tiwari, whose account seems fake as there is no activity on the profile.
It has more than 500 shares, added Surjewala.
Earlier, another Congress spokesperson Priyanka Chaturvedi was misquoted in a fake news circulated on social networking sites and then threatened along with her 10-year-old daughter through a vicious message posted by a person, now in police custody, on his Twitter handle.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer
New Delhi (PTI): An associate professor at Jamia Millia Islamia has been awarded a research grant of approximately Rs 94 lakh by the prestigious ICMR to support research in leveraging Artificial Intelligence for treatment of breast cancer.
The Indian Council of Medical Research (ICMR) has granted funding to Raza to develop cutting-edge tools for AI-guided drug design, focusing on optimising drug compounds, identifying therapeutic targets, and formulating novel treatment strategies for breast cancer, a statement by the varsity said on Friday.
One such promising drug compound 'DdpMPyPEPhU' already patented by Raza will be further explored under this initiative, the statement said.
This research will address critical challenges in breast cancer treatment and is expected to yield transformative outcomes that could impact healthcare practices globally, it added.
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment.
Jamia Vice-Chancellor Mazhar Asif and Registrar Md. Mahtab Alam Rizvi congratulated Raza on this accomplishment.
Asif stated, “This is a moment of immense pride for JMI. Raza’s recognition by ICMR underscores the university’s commitment to fostering research excellence and innovation. His groundbreaking work showcases JMI’s vital contributions to integrating AI in healthcare research.”
Expressing gratitude for the recognition, Raza said, “I am deeply honoured to receive this grant from ICMR. It represents a tremendous opportunity to advance our research on AI- driven drug design and contribute to better health outcomes for millions. I am thankful to my research team, collaborators and ICMR for their unwavering support.”
Raza is known for his research in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
